Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FCMZQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,424
Award facts
- Contract value 100% obligated
- $3,424.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,424.44 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml auto-injectors, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was issued on September 8, 2025, with performance to take place in Park Ridge, Illinois. The award utilized no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business. The product being delivered—Xolair auto-injectors—represents a specialized pharmaceutical supply used in military and federal healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. As a woman-owned small business pharmaceutical wholesaler established since 2001, DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. The company's extensive contract portfolio with the DLA demonstrates consistent success in providing specialized pharmaceutical products, including auto-injectors, oncology treatments, vaccines, and other medical supplies supporting military health operations.
Quick answers
Who was awarded contract SPE2DB25FCMZQ?
SPE2DB25FCMZQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FCMZQ worth?
The government has obligated $3,424 on SPE2DB25FCMZQ.
Is contract SPE2DB25FCMZQ an order under another contract?
Yes. SPE2DB25FCMZQ is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMZQ competed?
The extent of competition for SPE2DB25FCMZQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award